We are a coalition of doctors, researchers, patients, and entrepreneurs pioneering a new approach to curing diseases through innovative outcome-based financing. We collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.
Our Target is Chronic Pancreatitis
The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments within 10 years. Mission: Cure is working to make that happen. Consulting with pancreatic experts from the nation’s top research and healthcare institutions, we developed a 10-year plan and are working to implement it.
OUR APPROACH
Financing Based On Patient Outcomes
Promising And Cost-Effective Methods To Cure Diseases
Active Collaboration Among Stakeholders
Partnerships With Impact Investors
The time is right to create a new model for curing disease. Exciting developments in genetics and data are making precision medicine a reality. Healthcare payers are moving toward value-based funding, especially for chronic diseases. And a new generation of impact investors—seeking to generate social and not just financial returns—have made curing disease a priority.
DONATE
We cannot do this without your support.
News from Mission: Cure
Now Seeking A Summer Volunteer Scientific Research Intern
About MISSION: CURE Mission: Cure was founded in 2017 to find effective treatments and, ultimately, a cure for pancreatitis, an extremely painful, degenerative, and costly disease. Led by Megan Golden, a leader in innovative, outcome-based financing such as “Social Impact Bonds,” and Linda Martin, a veteran technology entrepreneur, Mission: Cure is pioneering a new funding model that creates new incentives…
Read More
Now Seeking A Summer Volunteer Creative Communications Intern
About Mission: Cure Mission: Cure was founded in 2017 to find effective treatments and, ultimately, a cure for pancreatitis, an extremely painful, degenerative and costly disease. Led by Megan Golden, a leader in innovative, outcome-based financing such as “Social Impact Bonds,” and Linda Martin, a veteran technology entrepreneur, Mission: Cure is pioneering a new funding model that creates new incentives…
Read More
Mission: Cure – Twitter